Agilent Technology introduces mass spectrometry systems at ASMS 2011 Agilent Technologies Inc.
Agilent Technology introduces mass spectrometry systems at ASMS 2011 Agilent Technologies Inc. today released mass spectrometry systems raising efficiency standards for biology and analytical chemistry analyses at the annual meeting of the American Culture of Mass Spectrometry erectile dysfunction medicine . ‘Our ultimate objective is to make all mass spec analysis routine, as users appearance at more and more complex samples even,’ stated Gustavo Salem, vice president and general manager, Agilent Biological Systems Division.
Agilent introduces first industrial RNA target enrichment system Agilent Technology, Inc., today introduced SureSelect RNA Catch Kits, the first commercial RNA target enrichment program enabling geneticists to spotlight particular genomic loci or transcripts of research interest. The RNA catch kits be able to precisely measure expression levels of genes of curiosity and detect allelic-particular expression, splicing events and gene fusions. We’re confident that researching novel therapeutic targets such as oncogenic fusions will help facilitate advancement of personalized medication for other cancers as well. At the Broad Institute, and marks the most recent development to emerge from Agilent’s ongoing collaboration with experts at the Broad. Agilent SureSelect RNA Catch improves the performance of RNA-seq for cancer research and is an essential tool for acquiring novel fusion genes from our tumor cDNA libraries, said Hiroyuki Mano, M.D., Ph.D, professor at Jichi Medical University and the University of Tokyo.